Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: A systematic review.

CONCLUSION: Data from both randomized and non-randomized studies suggest that AdoMet improves some biochemical liver parameters and symptoms of cholestasis within 2 wk, with further improvements observed in some studies after 4 and 8 wk of treatment. PMID: 32184941 [PubMed]
Source: World Journal of Hepatology - Category: Gastroenterology Tags: World J Hepatol Source Type: research